Evidence map›Paper›PMID 27900014›Full record

ArticleOncology letters2016

Pituicytoma: A report of three cases and literature review.

Xiaoyu Yang, Xiaoliang Liu, Wensen Li, Dawei Chen

Abstract read
In one paragraph

Article in Oncology letters, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Primary tumors of the posterior pituitary: A systematic review.Reviews in endocrine & metabolic disorders · 2019
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Pituicytoma: A rare case report of sellar and suprasellar tumor.International journal of surgery case reports · 2022
    Article
  12. Review
  13. Article
  14. Article
  15. [Pituitary gland tumors].Der Radiologe · 2019
    Review
  16. Article
  17. Clinical features, diagnosis and therapy of pituicytoma: an update.Journal of endocrinological investigation · 2019
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xiaoyu YangDepartment of Neurosurgery, First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.
Xiaoliang LiuDepartment of Neurosurgery, First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.
Wensen LiDepartment of Neurosurgery, First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.
Dawei ChenDepartment of Neurosurgery, First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pituicytoma is a rare tumor of the sellar and suprasellar regions, arising from the pituicytes, which are specialized glial cells in the neurohypophysis and infundibulum. Due to its rarity, ambiguity persists over the diagnosis, management and prognosis of pituicytoma. The current study presents a case series of three patients, each with a histopathological diagnosis of pituicytoma. A summary of the clinical manifestations, radiological characteristics, histopathological features, treatment strategies and prognoses are presented. In addition, 78 cases of pituicytoma, identified in a search of the published literature in Pubmed, are profiled. Pituicytoma typically presents with dysfunction of the optic nerve and pituitary. The radiological characteristics are nonspecific; diagnosis is typically made on the basis of histopathological results. The tumor is slow growing and benign and is amenable to surgical treatment by gross total resection; subsequent tumor recurrence is rare. A definitive assessment of prognosis requires an extended follow-up in a larger cohort.

Indexed as

infundibulomapathological diagnosispituicytomapituitary adenomasurgery

Identifiers

PMID27900014
PMCPMC5103963

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.